James S. O’Donnell

12.0k total citations · 2 hit papers
226 papers, 7.4k citations indexed

About

James S. O’Donnell is a scholar working on Hematology, Immunology and Internal Medicine. According to data from OpenAlex, James S. O’Donnell has authored 226 papers receiving a total of 7.4k indexed citations (citations by other indexed papers that have themselves been cited), including 140 papers in Hematology, 45 papers in Immunology and 32 papers in Internal Medicine. Recurrent topics in James S. O’Donnell's work include Platelet Disorders and Treatments (94 papers), Blood Coagulation and Thrombosis Mechanisms (48 papers) and Blood groups and transfusion (48 papers). James S. O’Donnell is often cited by papers focused on Platelet Disorders and Treatments (94 papers), Blood Coagulation and Thrombosis Mechanisms (48 papers) and Blood groups and transfusion (48 papers). James S. O’Donnell collaborates with scholars based in Ireland, United Kingdom and United States. James S. O’Donnell's co-authors include Michael Laffan, P. Vincent Jenkins, Jamie M. O’Sullivan, Roger J. S. Preston, Dennis McGonagle, Charlie Bridgewood, Κassem Sharif, Richard A. Manning, Paul Emery and Owen Smith and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

James S. O’Donnell

214 papers receiving 7.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia

2020 543 citations James S. O’Donnell et al. profile →
ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease

2021 285 citations Paula James, Jorge Di Paola et al. Blood Advances profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
James S. O’Donnell	3.8k	1.1k	1.1k	1.0k	1.0k	226	7.4k
Shoshana Revel‐Vilk	2.1k 0.6×	899 0.8×	557 0.5×	364 0.4×	731 0.7×	159	5.8k
Craig M. Kessler	6.7k 1.8×	879 0.8×	552 0.5×	129 0.1×	2.4k 2.3×	294	11.6k
Beng H. Chong	5.6k 1.5×	1.1k 1.0×	290 0.3×	240 0.2×	3.1k 3.1×	211	11.1k
Philippe de Moerloose	3.2k 0.8×	697 0.6×	146 0.1×	184 0.2×	1.7k 1.7×	220	8.2k
C. Erik Hack	1.8k 0.5×	1.8k 1.6×	409 0.4×	96 0.1×	497 0.5×	131	7.0k
Owen Smith	2.0k 0.5×	957 0.9×	304 0.3×	123 0.1×	356 0.4×	152	5.3k
Harvey G. Klein	2.5k 0.7×	918 0.8×	438 0.4×	145 0.1×	197 0.2×	189	7.9k
Donald H. Mahoney	1.7k 0.4×	220 0.2×	311 0.3×	543 0.5×	369 0.4×	156	4.8k
Josep‐María Ribera	4.5k 1.2×	1.1k 1.0×	259 0.2×	798 0.8×	111 0.1×	432	9.6k
Marilyn J. Manco‐Johnson	6.5k 1.7×	162 0.1×	269 0.3×	245 0.2×	1.9k 1.9×	239	8.5k

Countries citing papers authored by James S. O’Donnell

Since Specialization

Citations

This map shows the geographic impact of James S. O’Donnell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James S. O’Donnell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James S. O’Donnell more than expected).

Fields of papers citing papers by James S. O’Donnell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James S. O’Donnell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James S. O’Donnell. The network helps show where James S. O’Donnell may publish in the future.

Co-authorship network of co-authors of James S. O’Donnell

This figure shows the co-authorship network connecting the top 25 collaborators of James S. O’Donnell. A scholar is included among the top collaborators of James S. O’Donnell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James S. O’Donnell. James S. O’Donnell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Atiq, Ferdows, Pamela A. Christopherson, Sandra L. Haberichter, et al.. (2025). Effect of age on ISTH-BAT scores and low VWF diagnosis in the Zimmerman Program. Blood Advances. 9(19). 4780–4789. 2 indexed citations

Chion, Alain, Ferdows Atiq, Sonia Águila, et al.. (2024). The aptamer BT200 blocks interaction of K1405-K1408 in the VWF-A1 domain with macrophage LRP1. Blood. 144(13). 1445–1456. 15 indexed citations

Atiq, Ferdows, Orla Rawley, Jamie M. O’Sullivan, et al.. (2024). R1205H (Vicenza) causes conformational changes in the von Willebrand factor D′D3 domains and enhances von Willebrand factor binding to clearance receptors LRP1 and SR-AI. Journal of Thrombosis and Haemostasis. 22(10). 2752–2760.

Kruip, Marieke J.H.A., Yvonne Henskens, Maartje van den Biggelaar, et al.. (2024). Bleeding disorder of unknown cause: an illustrated review on current practice, knowledge gaps, and future perspectives. Research and Practice in Thrombosis and Haemostasis. 8(8). 102625–102625. 1 indexed citations

O’Donnell, James S. & Ross Baker. (2023). Low von Willebrand Disease: A Bleeding Disorder of Unknown Cause?. Hämostaseologie. 43(1). 44–51. 5 indexed citations

Karampini, Ellie, Helen Fogarty, Colm Bergin, et al.. (2023). Endothelial cell activation, Weibel-Palade body secretion, and enhanced angiogenesis in severe COVID-19. Research and Practice in Thrombosis and Haemostasis. 7(2). 100085–100085. 9 indexed citations

Chion, Alain, Sonia Águila, Judicaël Fazavana, et al.. (2023). OC 08.4 Aptamer BT200 Prolongs VWF Half-Life by Blocking Interaction with Macrophage Scavenger Receptor LRP1. Research and Practice in Thrombosis and Haemostasis. 7. 100541–100541. 2 indexed citations

Musgrave, Kathryn, et al.. (2022). Practical treatment guidance for cancer-associated thrombosis – Managing the challenging patient: A consensus statement. Critical Reviews in Oncology/Hematology. 171. 103599–103599. 7 indexed citations

Gardner, Richard A., Alessandro N. Franciosi, Cormac McCarthy, et al.. (2022). Nanoparticle Biomolecular Corona-Based Enrichment of Plasma Glycoproteins for N-Glycan Profiling and Application in Biomarker Discovery. ACS Nano. 16(4). 5463–5475. 39 indexed citations

10.

Dhami, Sukhraj Pal Singh, Claire Comerford, Brenton Cavanagh, et al.. (2022). Breast cancer cells mediate endothelial cell activation, promoting von Willebrand factor release, tumor adhesion, and transendothelial migration. Journal of Thrombosis and Haemostasis. 20(10). 2350–2365. 34 indexed citations

11.

Townsend, Liam, Helen Fogarty, Adam H. Dyer, et al.. (2021). Prolonged elevation of D‐dimer levels in convalescent COVID‐19 patients is independent of the acute phase response. Journal of Thrombosis and Haemostasis. 19(4). 1064–1070. 120 indexed citations

12.

Rehill, Aisling M., et al.. (2020). Apolipoprotein A-I enhances activated protein C cytoprotective activity. Blood Advances. 4(11). 2404–2408. 6 indexed citations

13.

Dunne, Eimear, Qin M. Qi, Eric S. G. Shaqfeh, et al.. (2019). Blood group alters platelet binding kinetics to von Willebrand factor and consequently platelet function. Blood. 133(12). 1371–1377. 32 indexed citations

14.

O’Sullivan, Joe M., Sonia Águila, Soracha E. Ward, et al.. (2016). N‐linked glycan truncation causes enhanced clearance of plasma‐derived von Willebrand factor. Journal of Thrombosis and Haemostasis. 14(12). 2446–2457. 30 indexed citations

15.

McGrath, Rachel T., Maartje van den Biggelaar, Barry J. Byrne, et al.. (2013). Altered glycosylation of platelet-derived von Willebrand factor confers resistance to ADAMTS13 proteolysis. Blood. 122(25). 4107–4110. 52 indexed citations

16.

O’Donnell, James S., et al.. (2013). Activated factor X signaling via protease-activated receptor 2 suppresses pro-inflammatory cytokine production from lipopolysaccharide-stimulated myeloid cells. Haematologica. 99(1). 185–193. 19 indexed citations

17.

Harris, Leanne F., et al.. (2010). Comparative study of Factor Xa fluorogenic substrates and their influence on the quantification of LMWHs. Analytical and Bioanalytical Chemistry. 399(2). 691–700. 7 indexed citations

18.

Harris, Leanne F., et al.. (2010). Development of a fluorescent anti-factor Xa assay to monitor unfractionated and low molecular weight heparins. Talanta. 81(4-5). 1725–1730. 15 indexed citations

19.

O’Donnell, James S., et al.. (1999). Bleeding symptoms and coagulation test abnormalities in 308 patients with AL amyloidosis. UCL Discovery (University College London).

20.

O’Donnell, James S.. (1970). The Center for Population Research. Journal of the American Veterinary Medical Association. 157(11). 1786–1794. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact